225Ac Purification from Irradiated 226Ra Targets
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing 225Ac from irradiated 226Ra targets result in products that are unsuitable for direct medical or pharmaceutical application due to significant impurities, making them unusable for radiopharmaceutical agents in cancer therapy.
Innovation Solution
A method involving leaching treatments with nitric or hydrochloric acid, followed by extraction chromatography using specific extractant systems to separate and purify 225Ac from 226Ra and other impurities, including a two-step process with different solid support materials and extractant systems to achieve a pharmaceutically acceptable 225Ac composition.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional production methods are used to produce 225Ac from irradiated 226Ra targets, then 225Ac can be obtained, but the product contains significant impurities making it unsuitable for medical application
Solution Approach 1:
The purification process is divided into multiple sequential steps: initial leaching with nitric or hydrochloric acid, first extraction chromatography to separate 225Ac from 226Ra and other impurities, and second extraction chromatography to remove remaining contaminants. Each step targets specific impurities, progressively increasing purity to pharmaceutical grade standards.
Solution Approach 2:
Extraction chromatography media serve as intermediary substances that selectively bind 225Ac from the complex mixture of irradiated target materials. The chromatography media act as a mediator between the crude product and the final purified form, enabling separation based on chemical affinity differences.
2Manufacturing precision
If simple purification methods are used, then the process is easy to operate, but the 225Ac product retains impurities unsuitable for pharmaceutical use
Solution Approach 1:
The purification process utilizes changes in chemical parameters including acid concentration (nitric or hydrochloric acid), flow rates, and column conditions to optimize separation at each stage. These parameter adjustments enable selective elution of 225Ac while retaining impurities, achieving high purity through controlled chemical environments.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method effectively purifies 225Ac, removing impurities and producing a composition suitable for further processing into radiopharmaceuticals, enhancing the quality and safety of 225Ac for medical use.
Implementation Method 1
separating 225Ac from 226Ra and other Ra-isotopes by means of at least one first extraction chromatography with a solid support material having a first extractant system coated thereon
Implementation Method 2
a first extractant system coated thereon, comprising at least one compound in accordance with general formula I in at least one compound in accordance with general formula II
Implementation Method 3
at least one leaching treatment of the 226Ra-targets for leaching essentially the entirety of 225Ac and 226Ra with nitric or hydrochloric acid under refluxing conditions
Implementation Method 4
separating 225Ac from 210Po and 210Pb by means of at least one second extraction chromatography with a solid support material having a second extractant system coated thereon
Implementation Method 5
a second extractant system coated thereon, comprising at least one compound in accordance with general formula III in at least one compound in accordance with general formula IV
Data Source
AI summary
The present invention describes a method for purification of 225Ac from irradiated 226Ra-targets provided on a support comprising a leaching treatment of the 225Ra-targets for leaching essentially for the entirety of 223Ac and 226Ra with nitric or hydrochloric acid, followed by a first extraction chromatography for separating 225Ac from 226Ra and other Ra-isotops and a second extraction chromotography for separating 225Ac from 210Po and 210Pb. The finally purified 225Ac can be used to prepare compositions useful for pharmaceutical purposes.